Epratuzumab and 90Y Epratuzumab for B cell non-Hodgkin lymphoma.
依帕珠单抗和钇-90标记的依帕珠单抗，用于B细胞非霍奇金淋巴瘤。
Lymphoma with signet ring cell features (LSF) is a rare morphologic variant of non-Hodgkin lymphoma.
印戒细胞型淋巴瘤(LSF)是非霍奇金淋巴瘤的一种罕见的形态变异。
Objective To research X-ray and CT findings and diagnosis of primary non-Hodgkin lymphoma of the bone.
目的探讨骨原发性非何杰金氏淋巴瘤的X线与CT表现及诊断要点。
Non-Hodgkin lymphoma is deadlier than Hodgkin lymphoma, and is expected to kill more than 20, 000 people in 2010.
非霍奇金淋巴瘤的死亡率比霍奇金淋巴瘤高，预测2010年美国死于该病症的人数将超过20 000。
To study the salvage treatment of relapsed or refractory intermediate-high aggressive non-Hodgkin lymphoma (NHL).
研究复发性、难治性中高度恶性非霍奇金淋巴瘤的解救治疗。
This paper reviewed the research advance on the role of environmental factors in the etiology of non-Hodgkin lymphoma.
本文就近年来环境因素在非霍奇金淋巴瘤病因中作用的研究进展作一综述。
Purpose: To understand the various CT findings of renal involvement of non-Hodgkin lymphoma (NHL) and leukemia in children.
目的：认识儿童非霍奇金淋巴瘤(NHL)及白血病肾脏浸润的各种CT表现。
The lymphomas are divided into two major categories: Hodgkin lymphoma and all other lymphomas, called non-Hodgkin lymphomas.
淋巴瘤可分为两大类：霍奇金淋巴瘤和其他的淋巴瘤，被称作非霍奇金淋巴瘤。
Objective To study the imaging features of primary bone non-Hodgkin lymphoma with an emphasis on MRI signal characteristics.
目的探讨骨原发性非霍奇金淋巴瘤的影像学特性，着重分析其MRI信号表现。
Objective To find differential expression protein by proteomic technology in non-Hodgkin lymphoma (NHL) and healthy controls.
目的：应用蛋白质组学技术寻找非霍奇金淋巴瘤与健康对照组血清中差异表达的蛋白。
Objective: To discuss the diagnosis, treatment and prognosis of the primary non-Hodgkin lymphoma in nose, pharynx and larynx.
目的：探讨鼻咽喉非霍奇金淋巴瘤的诊断、治疗和预后。
The hepatitis C virus (HVC) had been linked previously to increased risk of a certain liver cancer and subtypes of non-Hodgkin lymphoma.
早前有研究认为丙型肝炎病毒（HVC）的感染与某些肝癌和非霍奇金淋巴瘤亚型的风险增加相关。
Objective To evaluate the clinical features of primary gastric non-Hodgkin lymphoma (PG-NHL) and improve its diagnosis and clinical outcome.
目的探讨原发性胃非何杰金淋巴瘤(PG -NHL)的临床特点，提高其诊治水平。
Its toxic effects on blood cells are well documented and it's known to cause different kinds of leukaemia, multiple myeloma and non-Hodgkin lymphoma.
它对血细胞的毒性作用已得到很好地记载，而且已知它导致不同类型的白血病、多发性骨髓瘤和非霍奇金淋巴瘤。
Objective: to evaluate the effectiveness of Etoposide or Mitoxantrone combined chemotherapy in the treatment for malignant non-Hodgkin lymphoma (NHL).
目的：探讨足叶乙甙或米托蒽醌联合化疗方案治疗非何杰金淋巴瘤的治疗效果。
The two major types, Hodgkin disease and non-Hodgkin lymphoma, each have several subtypes. Diagnosis of either type requires Biopsy, usually from the lymph nodes.
通常分为两型︰霍奇金氏病和非霍奇金氏淋巴瘤，每一型又可进一步细分。这两种类型都需要靠活组织检查来诊断，常取自淋巴结。
Positive associations between birth order and non-Hodgkin lymphoma (NHL) have been interpreted as an effect of increased likelihood of early-life exposure to infections.
出生次序和非霍奇金淋巴瘤(NHL)的正相关性是由于早期生活中感染可能性增加影响。
Objective To increase the identification of non-Hodgkin lymphoma (NHL) with deep venous thrombosis (DVT), reduce the misdiagnosis and improve the awareness of prophylaxis.
目的提高对非霍奇金淋巴瘤(NHL)伴深静脉血栓(DVT)形成的认识，减少临床漏诊、误诊。
Objective To make the clinical practitioners a better understanding of the Primary Extra-node Non-Hodgkin Lymphoma (PENL) and reduce the misdiagnosis of PENL in early stage.
目的提高临床各专科医师对原发性结外非霍奇金淋巴瘤(PENL)的认识，减少PENL的早期误诊。
Objective To explore the treatment methods and effect of peripheral blood hematopoietic stem cell transplantation(PBSCT) for high-risk non-Hodgkin lymphoma(NHL) in children.
目的探讨外周血造血干细胞移植（PBSCT）治疗高危非霍奇金病患儿（NHL）的方法和疗效。
They show that a specific protein can be used as a 'biomarker' to identify which patients with a rare type of non-Hodgkin lymphoma would benefit from a new class of cancer drug.
他们展示了一种可以当做“生物标记物”特殊的蛋白，鉴别出使用新型肿瘤药物有效的稀有类型非霍奇金淋巴瘤的病人。
Methods: the clinical data of 64 primary nasal, pharyngeal and laryngeal non-Hodgkin lymphomas were retrospectively reviewed. The prognostic factors of the lymphoma were evaluated.
方法：回顾分析鼻咽喉非霍奇金淋巴瘤64例的临床资料，评价影响淋巴瘤的预后因素。
To evaluate outcome and prognosis of patients with T-cell lymphoma we analyzed 343 patients treated within trials of the German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL).
为了评价T细胞淋巴瘤患者的转归与预后，我们分析了德国高度非霍奇金淋巴瘤研究小组（DSHNHL）进行的临床试验中治疗的343例患者。
Methods To evaluate the prognostic factors related to long-term survival in patients with non-Hodgkin Lymphoma(NHL). 110 patients with NHL were reviewed retrospectively from Jan. 1995 to Jan. 2003.
方法统计1995年1月-2003年1月确诊的110例NHL患者生存率，并对性别、病理类型、临床分期、治疗方法、初治疗效等相关因素进行分析。
Systemic ALCL is a rare malignant tumor (non-Hodgkin lymphoma) that may appear in several parts of the body including the lymph nodes, skin, bones, soft tissue, lungs or liver, according to the NCI.
据NCI称，系统性alcl是一种罕见的恶性肿瘤(非霍奇金淋巴瘤)，可见于身体多个部位，包括淋巴结、皮肤、骨骼、软组织、肺或肝。
Radiotherapy may also be used in some cases of Non Hodgkin lymphoma.
放射治疗也可用于在某些情况下，非霍奇金淋巴瘤。
Purpose: To study the salvage treatment of recurrent intermediate-high grade non Hodgkin lymphoma (NHL).
目的：研究复发性中高度非霍奇金淋巴瘤的解救治疗。
Objective To investigate the relationship between pathomorphological features and clinical manifestations of non Hodgkin′s lymphoma (NHL) with bone marrow involvement (BMI).
目的探讨非霍奇金淋巴瘤（NHL）侵犯骨髓（BMI）的病理形态学特点及与临床表现的关系。
Objective To investigate an effective therapy for gastrointestinal non - Hodgkin lymphoma (NHL).
目的探讨胃肠道非霍奇金淋巴瘤(NHL)的治疗方法。
Objective To investigate an effective therapy for gastrointestinal non - Hodgkin lymphoma (NHL).
目的探讨胃肠道非霍奇金淋巴瘤(NHL)的治疗方法。
应用推荐